You said the national pharmaceutical strategy that came in a couple of years ago actually limits new therapies and creates regulatory hurdles. Can you talk a little more about that? This is the first I have heard of that problem.
October 25th, 2006 / 10:15 a.m.
Conservative
Diane Ablonczy Conservative Calgary Nose Hill, AB
You said the national pharmaceutical strategy that came in a couple of years ago actually limits new therapies and creates regulatory hurdles. Can you talk a little more about that? This is the first I have heard of that problem.
See context to find out what was said next.